Detalles de la búsqueda
1.
Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes.
Qual Life Res
; 30(7): 2033-2043, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33886044
2.
The Prime Diabetes Model: Novel Methods for Estimating Long-Term Clinical and Cost Outcomes in Type 1 Diabetes Mellitus.
Value Health
; 20(7): 985-991, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28712629
3.
Utilities for Complications Associated with Type 2 Diabetes: A Review of the Literature.
Adv Ther
; 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38771477
4.
Evaluating the Impact of Therapy on Quality of Life in Type 2 Diabetes: A Literature Review of Utilities Associated with Treatment-Related Attributes.
Patient Relat Outcome Meas
; 13: 97-111, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35586269
5.
The PRIME Type 2 Diabetes Model: a novel, patient-level model for estimating long-term clinical and cost outcomes in patients with type 2 diabetes mellitus.
J Med Econ
; 25(1): 393-402, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35105267
6.
Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain.
Diabetes Ther
; 12(5): 1535-1551, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33860927
7.
Treatment Patterns and Persistence With GLP-1 RA Treatments Among Patients With Type 2 Diabetes in France: A Retrospective Cohort Analysis.
Diabetes Ther
; 12(5): 1553-1567, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33864629
8.
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics.
Diabetes Ther
; 12(7): 1929-1946, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34097244
9.
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes.
Diabetes Ther
; 11(10): 2383-2399, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32880876
10.
GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data.
Diabetes Ther
; 10(3): 1067-1088, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31028689
11.
Utilization patterns of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus in Germany: a retrospective cohort study.
Curr Med Res Opin
; 35(5): 893-901, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30328731
12.
A cost-utility analysis of dulaglutide versus insulin glargine as third-line therapy for Type 2 diabetes in Canada.
J Comp Eff Res
; 8(4): 229-240, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30644328
13.
Patient preferences and health state utilities associated with dulaglutide and semaglutide injection devices among patients with type 2 diabetes in Italy.
J Med Econ
; 22(8): 806-813, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31010349
14.
Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK.
Drugs R D
; 19(2): 213-225, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31115873
15.
Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study.
Diabetes Ther
; 9(2): 789-801, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29525885
16.
The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France.
Diabetes Ther
; 9(1): 13-25, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29134607
17.
Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes.
Patient Prefer Adherence
; 12: 971-979, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29922043
18.
The cost-effectiveness of dulaglutide versus liraglutide for the treatment of type 2 diabetes mellitus in Spain in patients with BMI ≥30 kg/m2.
J Med Econ
; 20(5): 443-452, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28008768
19.
GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries.
Diabetes Ther
; 8(1): 115-128, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28070733
20.
Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes.
Clinicoecon Outcomes Res
; 8: 559-571, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27785079